Last reviewed · How we verify
Comparator: Placebo matching RotaTeq™ — Competitive Intelligence Brief
phase 3
Immunology/Infectious Disease
Biologic
Live · refreshed every 30 min
Target snapshot
Comparator: Placebo matching RotaTeq™ (Comparator: Placebo matching RotaTeq™) — Merck Sharp & Dohme LLC. This is a placebo comparator arm in a RotaTeq clinical trial, not an active drug.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Comparator: Placebo matching RotaTeq™ TARGET | Comparator: Placebo matching RotaTeq™ | Merck Sharp & Dohme LLC | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Comparator: Placebo matching RotaTeq™ CI watch — RSS
- Comparator: Placebo matching RotaTeq™ CI watch — Atom
- Comparator: Placebo matching RotaTeq™ CI watch — JSON
- Comparator: Placebo matching RotaTeq™ alone — RSS
Cite this brief
Drug Landscape (2026). Comparator: Placebo matching RotaTeq™ — Competitive Intelligence Brief. https://druglandscape.com/ci/comparator-placebo-matching-rotateq. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab